File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S2468-1253(19)30119-0
- Scopus: eid_2-s2.0-85066415366
- PMID: 30981686
- WOS: WOS:000470096400018
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A global scientific strategy to cure hepatitis B
Title | A global scientific strategy to cure hepatitis B |
---|---|
Authors | Revill, PAChisari, FVBlock, JMDandr, MGehring, AJGuo, HHu, JKramvis, ALampertico, PJanssen, HLALevrero, MLi, WLiang, TJLim, SGLu, FPenicaud, MCTavis, JEThimme, RArbuthnot, PBoonstra, AChang, KMChen, PJGlebe, DGuidotti, LGFellay, JFerrari, CJansen, LLau, DTYLok, ASMaini, MKMason, WMatthews, GParaskevis, DPeterse, JRehermann, BShin, ECThompson, Avan Bömmel, FWang, FSWatashi, KYang, HCYuan, ZYuen, MFBlock, TMiller, VProtzer, UBréchot, CLocarnini, SPeters, MGSchinazi, RFZoulim, F |
Issue Date | 2019 |
Publisher | Elsevier: Lancet. The Journal's web site is located at http://www.sciencedirect.com/science/journal/24681253 |
Citation | The Lancet Gastroenterology & Hepatology, 2019, v. 4 n. 7, p. 545-558 How to Cite? |
Abstract | Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide. |
Persistent Identifier | http://hdl.handle.net/10722/275113 |
ISSN | 2023 Impact Factor: 30.9 2023 SCImago Journal Rankings: 8.957 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Revill, PA | - |
dc.contributor.author | Chisari, FV | - |
dc.contributor.author | Block, JM | - |
dc.contributor.author | Dandr, M | - |
dc.contributor.author | Gehring, AJ | - |
dc.contributor.author | Guo, H | - |
dc.contributor.author | Hu, J | - |
dc.contributor.author | Kramvis, A | - |
dc.contributor.author | Lampertico, P | - |
dc.contributor.author | Janssen, HLA | - |
dc.contributor.author | Levrero, M | - |
dc.contributor.author | Li, W | - |
dc.contributor.author | Liang, TJ | - |
dc.contributor.author | Lim, SG | - |
dc.contributor.author | Lu, F | - |
dc.contributor.author | Penicaud, MC | - |
dc.contributor.author | Tavis, JE | - |
dc.contributor.author | Thimme, R | - |
dc.contributor.author | Arbuthnot, P | - |
dc.contributor.author | Boonstra, A | - |
dc.contributor.author | Chang, KM | - |
dc.contributor.author | Chen, PJ | - |
dc.contributor.author | Glebe, D | - |
dc.contributor.author | Guidotti, LG | - |
dc.contributor.author | Fellay, J | - |
dc.contributor.author | Ferrari, C | - |
dc.contributor.author | Jansen, L | - |
dc.contributor.author | Lau, DTY | - |
dc.contributor.author | Lok, AS | - |
dc.contributor.author | Maini, MK | - |
dc.contributor.author | Mason, W | - |
dc.contributor.author | Matthews, G | - |
dc.contributor.author | Paraskevis, D | - |
dc.contributor.author | Peterse, J | - |
dc.contributor.author | Rehermann, B | - |
dc.contributor.author | Shin, EC | - |
dc.contributor.author | Thompson, A | - |
dc.contributor.author | van Bömmel, F | - |
dc.contributor.author | Wang, FS | - |
dc.contributor.author | Watashi, K | - |
dc.contributor.author | Yang, HC | - |
dc.contributor.author | Yuan, Z | - |
dc.contributor.author | Yuen, MF | - |
dc.contributor.author | Block, T | - |
dc.contributor.author | Miller, V | - |
dc.contributor.author | Protzer, U | - |
dc.contributor.author | Bréchot, C | - |
dc.contributor.author | Locarnini, S | - |
dc.contributor.author | Peters, MG | - |
dc.contributor.author | Schinazi, RF | - |
dc.contributor.author | Zoulim, F | - |
dc.date.accessioned | 2019-09-10T02:35:42Z | - |
dc.date.available | 2019-09-10T02:35:42Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | The Lancet Gastroenterology & Hepatology, 2019, v. 4 n. 7, p. 545-558 | - |
dc.identifier.issn | 2468-1253 | - |
dc.identifier.uri | http://hdl.handle.net/10722/275113 | - |
dc.description.abstract | Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide. | - |
dc.language | eng | - |
dc.publisher | Elsevier: Lancet. The Journal's web site is located at http://www.sciencedirect.com/science/journal/24681253 | - |
dc.relation.ispartof | The Lancet Gastroenterology & Hepatology | - |
dc.title | A global scientific strategy to cure hepatitis B | - |
dc.type | Article | - |
dc.identifier.email | Yuen, MF: mfyuen@hku.hk | - |
dc.identifier.authority | Yuen, MF=rp00479 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1016/S2468-1253(19)30119-0 | - |
dc.identifier.pmid | 30981686 | - |
dc.identifier.pmcid | PMC6732795 | - |
dc.identifier.scopus | eid_2-s2.0-85066415366 | - |
dc.identifier.hkuros | 304383 | - |
dc.identifier.volume | 4 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 545 | - |
dc.identifier.epage | 558 | - |
dc.identifier.isi | WOS:000470096400018 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 2468-1156 | - |